Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak, AnilTanrikulu, Funda PepedilDurusoy, Salih SertacGurkan, EmelKaya, EminUmit, Elif G.Yavasoglu, Irfan2024-06-122024-06-1220190006-49711528-0020https://doi.org/10.1182/blood-2019-126402https://hdl.handle.net/20.500.14551/2590561st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 -- Orlando, FL[Abstract Not Available]en10.1182/blood-2019-126402info:eu-repo/semantics/openAccess[No Keywords]Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter StudyConference Object134Q1WOS:000577164606194